# Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa

> **NCT00830856** · NA · COMPLETED · sponsor: **University of Zimbabwe** · enrollment: 54 (actual)

## Conditions studied

- Cryptococcal Meningitis
- HIV Infections

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Fixed dose - Stavudine, lamivudine and Nevirapine
- **DRUG:** Fixed dose - Stavudine, Lamivudine, Nevirapine

## Key facts

- **NCT ID:** NCT00830856
- **Lead sponsor:** University of Zimbabwe
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-10
- **Final completion:** 2009-10
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830856, "Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00830856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*